Why the World needs Catalysts?
’Catalysts to patient access and pricing success for better public health – worldwide.’ This is our motto. Based on Renáta Vincze’s writing, we see how important catalysts can be.
’Catalysts to patient access and pricing success for better public health – worldwide.’ This is our motto. Based on Renáta Vincze’s writing, we see how important catalysts can be.
This 5 years of research explores how external reference pricing (ERP, or also called as IRP – International Reference Pricing) is used to set pharmaceutical prices to improve affordability, but how its application may have negative consequences on patient access across certain countries.
At the beginning of October we have delivered the result of a MarketScout service project and our client was really satisfied. Read their feedback!
Get in touch with us and schedule a demo.
Error: Contact form not found.
The PRiMA Headlines Newsletter provides a monthly overview of developments in Pricing, Reimbursement and Market Access developments across the globe. Since its launch in June 2015 we have covered more than 5,000 stories from over 100 countries.